BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27316391)

  • 1. Bone regeneration strategies with bone marrow stromal cells in orthopaedic surgery.
    Stanovici J; Le Nail LR; Brennan MA; Vidal L; Trichet V; Rosset P; Layrolle P
    Curr Res Transl Med; 2016; 64(2):83-90. PubMed ID: 27316391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of bone-graft substitutes in large bone defects: any specific needs?
    Calori GM; Mazza E; Colombo M; Ripamonti C
    Injury; 2011 Sep; 42 Suppl 2():S56-63. PubMed ID: 21752369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthopaedic applications of bone graft & graft substitutes: a review.
    Nandi SK; Roy S; Mukherjee P; Kundu B; De DK; Basu D
    Indian J Med Res; 2010 Jul; 132():15-30. PubMed ID: 20693585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The association of stromal mesenchymal cells with the bone substitute for the treatment of non-union of long bones, an alternative to autologous spongy grafts: a case report].
    Chagou A; Benameur H; Hassoun J; Abdeloihab J
    Pan Afr Med J; 2020; 37():234. PubMed ID: 33552352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone tissue engineering for bone defect therapy].
    Boos AM; Arkudas A; Kneser U; Horch RE; Beier JP
    Handchir Mikrochir Plast Chir; 2010 Dec; 42(6):360-8. PubMed ID: 20821364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study on the Application of Mesenchymal Stromal Cells Combined with Tricalcium Phosphate Scaffold into Femoral Bone Defects.
    Šponer P; Kučera T; Brtková J; Urban K; Kočí Z; Měřička P; Bezrouk A; Konrádová Š; Filipová A; Filip S
    Cell Transplant; 2018 Oct; 27(10):1459-1468. PubMed ID: 30203687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell therapy: is there a future for reconstruction of large bone defects?
    Watanabe Y; Harada N; Sato K; Abe S; Yamanaka K; Matushita T
    Injury; 2016 Jan; 47 Suppl 1():S47-51. PubMed ID: 26768292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of autologous bone marrow stromal cells differentiated on scaffolds for canine tibial bone reconstruction.
    Özdal-Kurt F; Tuğlu I; Vatansever HS; Tong S; Deliloğlu-Gürhan SI
    Biotech Histochem; 2015; 90(7):516-28. PubMed ID: 25994048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefabrication of vascularized bone grafts using a combination of bone marrow mesenchymal stem cells and vascular bundles with β-tricalcium phosphate ceramics.
    Dong Z; Li B; Zhao J; Ma Q; Bai S; Yang W; Li G; Ma G; Liu Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5 Suppl):S153-9. PubMed ID: 23063392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allograft bone matrix versus synthetic bone graft substitutes.
    Zimmermann G; Moghaddam A
    Injury; 2011 Sep; 42 Suppl 2():S16-21. PubMed ID: 21889142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells.
    van Gastel N; Torrekens S; Roberts SJ; Moermans K; Schrooten J; Carmeliet P; Luttun A; Luyten FP; Carmeliet G
    Stem Cells; 2012 Nov; 30(11):2460-71. PubMed ID: 22911908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease.
    Lebouvier A; Poignard A; Coquelin-Salsac L; Léotot J; Homma Y; Jullien N; Bierling P; Galactéros F; Hernigou P; Chevallier N; Rouard H
    Stem Cell Res; 2015 Nov; 15(3):584-594. PubMed ID: 26492634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow-derived mesenchymal stem cells-directed bone regeneration in the dog mandible: a comparison between biphasic calcium phosphate and natural bone mineral.
    Jafarian M; Eslaminejad MB; Khojasteh A; Mashhadi Abbas F; Dehghan MM; Hassanizadeh R; Houshmand B
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):e14-24. PubMed ID: 18442730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of six bone-graft substitutes regarding to cell seeding efficiency, metabolism and growth behaviour of human mesenchymal stem cells (MSC) in vitro.
    Seebach C; Schultheiss J; Wilhelm K; Frank J; Henrich D
    Injury; 2010 Jul; 41(7):731-8. PubMed ID: 20233614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells - a comparison of different tissue sources.
    Stockmann P; Park J; von Wilmowsky C; Nkenke E; Felszeghy E; Dehner JF; Schmitt C; Tudor C; Schlegel KA
    J Craniomaxillofac Surg; 2012 Jun; 40(4):310-20. PubMed ID: 21723141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of bone graft substitutes in large cancellous voids: any specific needs?
    Faour O; Dimitriou R; Cousins CA; Giannoudis PV
    Injury; 2011 Sep; 42 Suppl 2():S87-90. PubMed ID: 21723553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: study of their biodistribution in the early time points after injection.
    Lebouvier A; Poignard A; Cavet M; Amiaud J; Leotot J; Hernigou P; Rahmouni A; Bierling P; Layrolle P; Rouard H; Chevallier N
    Stem Cell Res Ther; 2015 Apr; 6(1):68. PubMed ID: 25889681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIA fractions contain mesenchymal stroma cells with high osteogenic potency.
    Kuehlfluck P; Moghaddam A; Helbig L; Child C; Wildemann B; Schmidmaier G;
    Injury; 2015 Dec; 46 Suppl 8():S23-32. PubMed ID: 26747914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds.
    Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S
    Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major bone defect treatment with an osteoconductive bone substitute.
    Paderni S; Terzi S; Amendola L
    Chir Organi Mov; 2009 Sep; 93(2):89-96. PubMed ID: 19711008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.